$MATK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MARTEK BIOSCIENCES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MARTEK BIOSCIENCES CORP. Get notifications about new insider transactions in MARTEK BIOSCIENCES CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Option Exercise | D | 27.83 | 10,000 | 278,300 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Option Exercise | M | 0.00 | 17,027 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Option Exercise | M | 0.00 | 8,709 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Option Exercise | M | 0.00 | 3,039 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Option Exercise | M | 0.00 | 2,836 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Sell | D | 31.50 | 31,881 | 1,004,252 | 0 | 31.9 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Grant | A | 0.00 | 31,881 | 0 | 31,881 | 0 to 31.9 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | M | 0.00 | 18,831 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | M | 0.00 | 10,037 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | M | 0.00 | 6,024 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | D | 27.97 | 35,000 | 978,950 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | D | 28.50 | 50,000 | 1,425,000 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | D | 14.56 | 50,000 | 728,000 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | M | 0.00 | 5,576 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Sell | D | 31.50 | 40,468 | 1,274,742 | 0 | 40.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Grant | A | 0.00 | 40,468 | 0 | 40,468 | 0 to 40.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Option Exercise | M | 0.00 | 18,831 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Option Exercise | M | 0.00 | 10,037 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Option Exercise | M | 0.00 | 6,024 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Option Exercise | M | 0.00 | 5,576 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Sell | D | 31.50 | 40,468 | 1,274,742 | 0 | 40.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Grant | A | 0.00 | 40,468 | 0 | 40,468 | 0 to 40.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Option Exercise | M | 0.00 | 10,580 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Option Exercise | M | 0.00 | 5,639 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Option Exercise | M | 0.00 | 3,384 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Option Exercise | M | 0.00 | 3,133 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Sell | D | 31.50 | 22,736 | 716,184 | 0 | 22.7 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Grant | A | 0.00 | 22,736 | 0 | 22,736 | 0 to 22.7 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Option Exercise | M | 0.00 | 24,312 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,959 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Option Exercise | M | 0.00 | 7,777 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Option Exercise | D | 17.18 | 25,400 | 436,372 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Option Exercise | M | 0.00 | 7,199 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Sell | D | 31.50 | 52,247 | 1,645,781 | 0 | 52.2 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Grant | A | 0.00 | 52,247 | 0 | 52,247 | 0 to 52.2 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | KELLER JEROME C | Director | Option Exercise | D | 27.97 | 35,000 | 978,950 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | KELLER JEROME C | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | KELLER JEROME C | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | KELLER JEROME C | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Option Exercise | M | 0.00 | 18,831 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Option Exercise | M | 0.00 | 10,037 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Option Exercise | M | 0.00 | 6,024 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Option Exercise | M | 0.00 | 5,576 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Sell | D | 31.50 | 40,468 | 1,274,742 | 0 | 40.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Grant | A | 0.00 | 40,468 | 0 | 40,468 | 0 to 40.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Option Exercise | D | 27.87 | 15,000 | 418,050 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Option Exercise | D | 28.50 | 15,000 | 427,500 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Option Exercise | D | 14.56 | 15,000 | 218,400 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Pernock David M | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Pernock David M | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Pernock David M | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MAYER ROBERT H | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MAYER ROBERT H | Director | Sell | D | 31.50 | 6,048 | 190,512 | 0 | 6 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MAYER ROBERT H | Director | Grant | A | 0.00 | 6,048 | 0 | 6,048 | 0 to 6 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Option Exercise | D | 27.87 | 15,000 | 418,050 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Option Exercise | D | 28.50 | 15,000 | 427,500 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Option Exercise | D | 14.56 | 15,000 | 218,400 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | KAWALEK POLLY B | Director | Option Exercise | D | 27.83 | 10,000 | 278,300 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | KAWALEK POLLY B | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | KAWALEK POLLY B | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | KAWALEK POLLY B | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 27.87 | 15,000 | 418,050 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 24.85 | 10,000 | 248,500 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 11.84 | 323 | 3,824 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | D'Andrea Harry J | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | D'Andrea Harry J | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | D'Andrea Harry J | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Devine Michael G | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Devine Michael G | Director | Sell | D | 31.50 | 2,533 | 79,790 | 0 | 2.5 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Devine Michael G | Director | Grant | A | 0.00 | 2,533 | 0 | 2,533 | 0 to 2.5 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BEERY JAMES | Director | Option Exercise | M | 0.00 | 2,533 | 0 | 0 | |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BEERY JAMES | Director | Sell | D | 31.50 | 6,048 | 190,512 | 0 | 6 K to 0 (-100.00 %) |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | BEERY JAMES | Director | Grant | A | 0.00 | 6,048 | 0 | 6,048 | 0 to 6 K |
Mar 01 2011 | MATK | MARTEK BIOSCIENCES ... | Royal DSM N.V. | 10% Owner | Buy | P | 31.50 | 15,712,946 | 494,957,799 | 45,755,200 | 30 M to 45.8 M (+52.30 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Sell | U | 31.50 | 3,840 | 120,960 | 0 | 3.8 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Sell | U | 31.50 | 22,879 | 720,689 | 0 | 22.9 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Sell | U | 31.50 | 19,042 | 599,823 | 0 | 19 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Sell | U | 31.50 | 1,293 | 40,730 | 0 | 1.3 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Sell | U | 31.50 | 5,687 | 179,141 | 0 | 5.7 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Sell | U | 31.50 | 1,000 | 31,500 | 0 | 1,000 to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Sell | U | 31.50 | 10,054 | 316,701 | 1,000 | 11.1 K to 1,000 (-90.95 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Sell | U | 31.50 | 11,134 | 350,721 | 0 | 11.1 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Sell | U | 31.50 | 25,273 | 796,100 | 0 | 25.3 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | Pernock David M | Director | Sell | U | 31.50 | 2,449 | 77,144 | 0 | 2.4 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Sell | U | 31.50 | 7,300 | 229,950 | 0 | 7.3 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Sell | U | 31.50 | 7,300 | 229,950 | 0 | 7.3 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Sell | U | 31.50 | 55,206 | 1,738,989 | 0 | 55.2 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Sell | U | 31.50 | 10,000 | 315,000 | 0 | 10 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Sell | U | 31.50 | 332,609 | 10,477,184 | 0 | 332.6 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | FLANAGAN ROBERT J | Director | Sell | U | 31.50 | 8,675 | 273,263 | 0 | 8.7 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | MAYER ROBERT H | Director | Sell | U | 31.50 | 3,847 | 121,181 | 0 | 3.8 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | KELLER JEROME C | Director | Sell | U | 31.50 | 11,456 | 360,864 | 0 | 11.5 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | KAWALEK POLLY B | Director | Sell | U | 31.50 | 9,456 | 297,864 | 0 | 9.5 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Sell | U | 31.50 | 32,462 | 1,022,553 | 0 | 32.5 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | Devine Michael G | Director | Sell | U | 31.50 | 5,270 | 166,005 | 0 | 5.3 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | D'Andrea Harry J | Director | Sell | U | 31.50 | 9,574 | 301,581 | 0 | 9.6 K to 0 (-100.00 %) |
Feb 25 2011 | MATK | MARTEK BIOSCIENCES ... | BEERY JAMES | Director | Sell | U | 31.50 | 4,941 | 155,642 | 0 | 4.9 K to 0 (-100.00 %) |
Feb 24 2011 | MATK | MARTEK BIOSCIENCES ... | Royal DSM N.V. | 10% Owner | Buy | P | 31.50 | 245,302 | 7,727,013 | 30,042,254 | 29.8 M to 30 M (+0.82 %) |
Feb 24 2011 | MATK | MARTEK BIOSCIENCES ... | Royal DSM N.V. | 10% Owner | Buy | P | 31.50 | 17,000 | 535,500 | 29,796,952 | 29.8 M to 29.8 M (+0.06 %) |
Feb 24 2011 | MATK | MARTEK BIOSCIENCES ... | Royal DSM N.V. | 10% Owner | Buy | P | 31.50 | 32 | 1,008 | 29,779,952 | 29.8 M to 29.8 M (0.00 %) |
Sep 21 2010 | MATK | MARTEK BIOSCIENCES ... | Pernock David M | Director | Option Exercise | M | 0.00 | 2,449 | 0 | 0 | |
Sep 21 2010 | MATK | MARTEK BIOSCIENCES ... | Pernock David M | Director | Buy | M | 0.00 | 2,449 | 0 | 2,449 | 0 to 2.4 K |
Jul 07 2010 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Buy | P | 20.96 | 2,000 | 41,926 | 32,462 | 30.5 K to 32.5 K (+6.57 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,509 | 0 | 10,037 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,008 | 0 | 6,024 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Option Exercise | M | 0.00 | 2,788 | 0 | 5,576 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Payment of Exercise | F | 23.88 | 2,372 | 56,643 | 11,054 | 13.4 K to 11.1 K (-17.67 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Nitze Peter A | Chief Operating Off ... | Buy | M | 0.00 | 7,305 | 0 | 13,426 | 6.1 K to 13.4 K (+119.34 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Option Exercise | M | 0.00 | 2,177 | 0 | 8,709 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Option Exercise | M | 0.00 | 1,103 | 0 | 3,309 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Option Exercise | M | 0.00 | 1,418 | 0 | 2,836 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Payment of Exercise | F | 23.88 | 1,540 | 36,775 | 5,687 | 7.2 K to 5.7 K (-21.31 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | Feitel David | Exec VP, Gen Counse ... | Buy | M | 0.00 | 4,698 | 0 | 7,227 | 2.5 K to 7.2 K (+185.77 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Option Exercise | M | 0.00 | 1,409 | 0 | 5,639 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Option Exercise | M | 0.00 | 1,128 | 0 | 3,384 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Option Exercise | M | 0.00 | 1,567 | 0 | 3,133 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Payment of Exercise | F | 23.88 | 1,375 | 32,835 | 19,042 | 20.4 K to 19 K (-6.73 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | EASTERLING BARNEY B JR | Sr VP Manufacturing | Buy | M | 0.00 | 4,104 | 0 | 20,417 | 16.3 K to 20.4 K (+25.16 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,239 | 0 | 12,959 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Option Exercise | M | 0.00 | 2,592 | 0 | 7,777 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,600 | 0 | 7,199 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Payment of Exercise | F | 23.88 | 3,089 | 73,765 | 30,462 | 33.6 K to 30.5 K (-9.21 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | DUBIN STEVE | Chief Executive Off ... | Buy | M | 0.00 | 9,431 | 0 | 33,551 | 24.1 K to 33.6 K (+39.10 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | M | 0.00 | 2,509 | 0 | 10,037 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | M | 0.00 | 2,008 | 0 | 6,024 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Option Exercise | M | 0.00 | 2,788 | 0 | 5,576 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Payment of Exercise | F | 23.88 | 2,393 | 57,145 | 22,879 | 25.3 K to 22.9 K (-9.47 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | BUZY PETER L | CFO, Treasurer and ... | Buy | M | 0.00 | 7,305 | 0 | 25,272 | 18 K to 25.3 K (+40.66 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Option Exercise | M | 0.00 | 2,509 | 0 | 10,037 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Option Exercise | M | 0.00 | 2,008 | 0 | 6,024 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Option Exercise | M | 0.00 | 2,788 | 0 | 5,576 | |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Payment of Exercise | F | 23.88 | 2,393 | 57,145 | 11,134 | 13.5 K to 11.1 K (-17.69 %) |
Mar 23 2010 | MATK | MARTEK BIOSCIENCES ... | ABRAMSON DAVID M | President | Buy | M | 0.00 | 7,305 | 0 | 13,527 | 6.2 K to 13.5 K (+117.41 %) |
Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Option Exercise | M | 0.00 | 3,515 | 0 | 0 | |
Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Option Exercise | A | 0.00 | 2,533 | 0 | 2,533 | |
Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | ROTBERG EUGENE H | Director | Buy | M | 0.00 | 3,515 | 0 | 55,206 | 51.7 K to 55.2 K (+6.80 %) |
Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | Pernock David M | Director | Option Exercise | A | 0.00 | 2,533 | 0 | 2,533 | |
Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | MAYER ROBERT H | Director | Option Exercise | A | 0.00 | 2,533 | 0 | 2,533 | |
Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Option Exercise | M | 0.00 | 3,515 | 0 | 0 | |
Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Option Exercise | A | 0.00 | 2,533 | 0 | 2,533 | |
Mar 22 2010 | MATK | MARTEK BIOSCIENCES ... | MACMASTER JR DOUGLAS J | Director | Buy | M | 0.00 | 3,515 | 0 | 25,273 | 21.8 K to 25.3 K (+16.15 %) |